Live Panel Schedule for Digital RESI September 2020

3 Sep

By Joey Wong, Investor Research Analyst, LSN

With only one week left, Digital RESI September 2020 is right around the corner! We are very excited to announce the live panel schedule for the conference.

All panels at Digital RESI September will be live-streamed. There will be two live panel sessions each day, starting as early as next week and will continue through the end of the conference, September 8-16. We welcome all Digital RESI September attendees to join and participate in these live sessions. Registered attendees can RSVP via the partnering platform to receive the dial-in information to join. For those who cannot make the live sessions, all the panel videos will be available via the virtual agenda.

It is worth noting that Global Investment and Partnership Panel, sponsored by Onelin Capital, is open to the public (no RESI registration required). Interested readers are welcome to RSVP here and participate in this panel.

Digital RESI September registrants will hear from the leading industry experts about their investment strategies and differentiated approaches, recent investments and areas of interest, and much more. If you haven’t already, register here for RESI September 2020 to participate in these live panels!

Below is the schedule for next week’s live panel sessions:

 

Corporate VC Panel – “The Corporate Landscape Morphed & New Opportunities Abound”

Date & Time: Tuesday, September 8, 10:00 – 10:50 am EST

  • Andy Merken (Moderator), Partner and Co-Chair, Life Sciences, Burns & Levinson
  • Lana Ghanem, Managing Director, Hikma Ventures
  • Mark Ralph, Executive Director, Boehringer Ingelheim Venture Fund
  • Tom Gibbs, Director, Debiopharm Innovation Fund

Medtech Strategics Panel – “Large Medical Device Firms Seeking External Innovation”

Date & Time: Tuesday, September 8, 12:00 – 12:50 pm EST

  • Geoff Dacosta (Moderator), Director of Business Development and Licensing, Medtronic
  • Christina Salys, Director of New Business development, Intuitive Surgical
  • David Uffer, Senior Partner, Alira Ventures
  • Rupert Winckler, Head of EMEA New Business Development, Olympus Corporation

Health System Partners Panel – “Care Providers and Payers Seek New Technologies”

Date & Time: Wednesday, September 9, 12:00 – 12:50 pm EST

  • Cyrll Philip, Principal, Providence Ventures
  • Linda Maxwell, Director, Biomedical Zone
  • Mayank Taneja, Director of Venture Investments, OSF Healthcare Ventures
  • Rajesh Aggarwal, Executive Vice President, Jefferson Strategic Ventures

Seed Funds Panel – “Investing in Emerging Science to Pursue High Rewards”

Date & Time: Wednesday, September 9, 2:00 – 2:50 pm EST

  • Gary Gershony (Moderator), Life Science Angels
  • Anya Roy, Head of Illumina Accelerator Cambridge, Illumina Accelerator
  • Jun Deng, Investment Partner, Joyance Partners
  • Nancy Kaufman, CEO, Beacon Capital
  • Prathna Ramesh, Executive Director, Maple Leaf Angels

Oncology Innovation Panel – “The Search for New Approaches to Diagnosing & Treating Cancer”

Date & Time: Thursday, September 10, 12:00 – 12:50 pm EST

  • Steve Yoder (Moderator), Vice President of Business Development, Taiho Oncology
  • Anthony Bajoras, Managing Director, Cancer Fund
  • Barbara Lavery, Chief Program Officer, Alliance for Cancer Gene Therapy
  • Duncan Young, Director of Search and Evaluation Oncology, Business Development & Licensing, AstraZeneca
  • Mark Krul, Partner, Aglala Oncology Fund

Global Investment and Partnership Panel – “Asia Firms Looking to Build Global Partnerships”

Date & Time: Thursday, September 10, 8:00 – 8:50 pm EST (Sponsored by Onelin Capital, Open to the public)

  • Judy Lee (Moderator), General Manager, Onelin Capital
  • Haolin Sung, Managing Partner, Chaperone Investment
  • Haruhiko Sugino, Director of Global Business Development, Otsuka Pharmaceuticals
  • Weiyong Sun, Senior Director of Specialty Medicine Search & Evaluation, Daichi Sankyo
  • Yao Li Ho, Senior Director of Business Development, LYFE Capital

Impact Investors Panel – “Life Science Investors Looking for More Than Financial Returns”

Date & Time: Friday, September 11, 12:00 – 12:50 pm EST

  • Lore Gruenbaum (Moderator), Vice President of Therapy Acceleration Program, Leukemia & Lymphoma Society
  • Chris Penland, Vice President of BioPharma Programs, Cystic Fibrosis Foundation
  • Kuldip Dave, Vice President of Research, ALS Association
  • Michael Cole, Founder and General Partner, Global Neurohealth Ventures
  • Paul Larkin, Manager of Research Innovation, Crohn’s and Colitis Foundation

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

<span>%d</span> bloggers like this: